semaglutide glp 1 receptor agonist GLP-1s GLP-1 Receptor Agonists Show Promise
Description
For patients with Type 2 diabetes who also have or are at high risk for cardiovascular disease, GLP-1 agonists offer a dual benefit that insulin cannot match
Zhao X, Wang M, Wen Z, Lu Z, Cui L, Fu C, et al
10.1001/jamaophthalmol.2024.2296 7 KanoskiS
Additionally, those with a history of pancreatitis are carefully assessed to ensure the treatment is safe
Call to Action Curious about whether GLP-1 therapies or future medications like retatrutide are right for you
The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health
